Corin Badiu
Endocrinology — Institutul Național de Endocrinologie C.I. Parhon, Romania
Corin Badiu
LeadR Profile
Endocrinology
Subspecialties: Cardiology - Oncology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1997 - 2026
Number : 254
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review. thyroid diseases, neoplasms, thyroid gland, adrenalectomy, diagnosis, therapeutics, hydrocortisone, mutation, cushing syndrome | Front Endocrinol (Lausanne) | 2026 | 0 |
| Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial. glucagon-like peptide 1, quality of life, safety, cardiovascular diseases, frailty, semaglutide | JAMA Cardiol | 2026 | 0 |
| Metyrapone-Associated Improvements in Health-Related Quality of Life in Cushing's Syndrome. quality of life, eating, metyrapone, multiple chronic conditions, hormones, signs and symptoms, therapeutics, hydrocortisone, cushing syndrome | Eur J Endocrinol | 2026 | 0 |
| Integration of hierarchical clustering in hematologic biomarkers prediction for endocrine toxicity during immunotherapy in lung cancer patients. lung, lymphocytes, neoplasms, carcinoma, non-small-cell lung, neutrophils, biomarkers, immunotherapy, lung neoplasms, cluster analysis, artificial intelligence | Sci Rep | 2026 | 0 |
| Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study. diabetes mellitus, glucocorticoids, hypertension, safety, pharmaceutical preparations, receptors, glucocorticoid, signs and symptoms, therapeutics, hydrocortisone, cushing syndrome | Lancet Diabetes Endocrinol Top journal | 2026 | 0 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A randomized placebo controlled trial to evaluate the safety and efficacy of Debio 4126 in patients with acromegaly previously treated with somatostatin analogs 2024-516616-24-00 — somatostatin, safety, acromegaly, octreotide | Phase 3 | Recruiting | 2025 |
| A Study of Pitolisant in Patients With Prader Willi Syndrome NCT06366464 — safety, tablets, problem behavior, prader-willi syndrome, disorders of excessive somnolence, sleepiness | Phase 3 | Recruiting | 2024 |
LeadR Networks
Main global connection map